Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
COYA
#3328
Coya Therapeutics, Inc. Common Stock
4.9
6
+1.22%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+1.22%
Monthly Change
+2.06%
6 month change
-25.30%
Year Change
-24.04%
Previous Close
4.9
0
Open
4.9
6
Bid
Ask
Low
4.9
6
High
4.9
6
Volume
2
Markets
US Stock Market
Healthcare
COYA
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2022
2023
2024
TTM
Dividends per share
—
—
—
—
Dividend yield %
—
—
—
—
Payout ratio %
—
—
—
—
News
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock with $18 target
Coya Therapeutics secures $11.1 million in private placement
Coya Therapeutics advances ALS and FTD clinical trials in 2026
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock at $18
Tracking David Einhorn’s Greenlight Capital Portfolio – Q3 2025 Update (NYSE:GRBK)
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock
H.C. Wainwright reaffirms Buy rating on Coya Therapeutics stock at $18 target
Coya Therapeutics closes $23 million public offering of common stock
Coya Therapeutics stock falls after pricing $20 million public offering
Coya Therapeutics prices $20 million public offering of common stock
Coya Therapeutics announces common stock offering to fund operations
Why David Einhorn’s Greenlight prefers this tiny biotech over AI ‘excitement’